Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 457

1.

Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis.

Águeda AF, Monti S, Luqmani RA, Buttgereit F, Cid M, Dasgupta B, Dejaco C, Mahr A, Ponte C, Salvarani C, Schmidt W, Hellmich B.

RMD Open. 2019 Sep 23;5(2):e001020. doi: 10.1136/rmdopen-2019-001020. eCollection 2019.

2.

Free-energy landscape of molecular interactions between endothelin 1 and human endothelin type B receptor: fly-casting mechanism.

Higo J, Kasahara K, Wada M, Dasgupta B, Kamiya N, Hayami T, Fukuda I, Fukunishi Y, Nakamura H.

Protein Eng Des Sel. 2019 Oct 11. pii: gzz029. doi: 10.1093/protein/gzz029. [Epub ahead of print]

PMID:
31608410
3.

Circulating interleukin-6 as a biomarker in a randomized controlled trial of modified-release prednisone vs immediate-release prednisolone, in newly diagnosed patients with giant cell arteritis.

Miler E, Stapleton PP, Mapplebeck S, Mackerness C, Gayford D, Aung T, Wilson L, Schofield P, Dasgupta B.

Int J Rheum Dis. 2019 Oct;22(10):1900-1904. doi: 10.1111/1756-185X.13702. Epub 2019 Sep 17.

PMID:
31531960
4.

'Slope sign': a feature of large vessel vasculitis?

Dasgupta B, Smith K, Khan AAS, Coath F, Wakefield RJ.

Ann Rheum Dis. 2019 Dec;78(12):1738. doi: 10.1136/annrheumdis-2019-216213. Epub 2019 Sep 13. No abstract available.

PMID:
31519653
5.

Reconstruction of low-resolution molecular structures from simulated atomic force microscopy images.

Dasgupta B, Miyashita O, Tama F.

Biochim Biophys Acta Gen Subj. 2019 Aug 28:129420. doi: 10.1016/j.bbagen.2019.129420. [Epub ahead of print]

PMID:
31472175
6.

Retroperitoneal fibrosis; a single-centre case experience with literature review.

Adnan S, Bouraoui A, Mehta S, Banerjee S, Jain S, Dasgupta B.

Rheumatol Adv Pract. 2018 Dec 10;3(1):rky050. doi: 10.1093/rap/rky050. eCollection 2019.

7.

2018 Update of the EULAR recommendations for the management of large vessel vasculitis.

Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G, Hollinger N, Mahr A, Mollan SP, Mukhtyar C, Ponte C, Salvarani C, Sivakumar R, Tian X, Tomasson G, Turesson C, Schmidt W, Villiger PM, Watts R, Young C, Luqmani RA.

Ann Rheum Dis. 2019 Jul 3. pii: annrheumdis-2019-215672. doi: 10.1136/annrheumdis-2019-215672. [Epub ahead of print]

PMID:
31270110
8.

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome.

Hackett KL, Davies K, Tarn J, Bragg R, Hargreaves B, Miyamoto S, McMeekin P, Mitchell S, Bowman S, Price EJ, Pease C, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Vadivelu S, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Lendrem DW, Ng WF.

RMD Open. 2019 Apr 24;5(1):e000885. doi: 10.1136/rmdopen-2018-000885. eCollection 2019.

9.

Responsiveness of Serum C-Reactive Protein, Interleukin-17A, and Interleukin-17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double-Blind, Placebo-Controlled Trials.

Siebert S, Sweet K, Dasgupta B, Campbell K, McInnes IB, Loza MJ.

Arthritis Rheumatol. 2019 Oct;71(10):1660-1669. doi: 10.1002/art.40921. Epub 2019 Sep 3.

PMID:
31070869
10.

Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial.

Sweet K, Dasgupta B, de Vries D, Gourley I, Hsu B, Loza MJ, Taylor PC.

Ann Rheum Dis. 2019 Oct;78(10):1439-1441. doi: 10.1136/annrheumdis-2019-215183. Epub 2019 Apr 24. No abstract available.

PMID:
31018960
11.

Collisional Triggering of Fast Flavor Conversions of Supernova Neutrinos.

Capozzi F, Dasgupta B, Mirizzi A, Sen M, Sigl G.

Phys Rev Lett. 2019 Mar 8;122(9):091101. doi: 10.1103/PhysRevLett.122.091101.

PMID:
30932530
12.

Identification of an activated neutrophil phenotype in polymyalgia rheumatica during steroid treatment: a potential involvement of immune cell cross-talk.

Nadkarni S, Lashin H, Hollywood J, Dasgupta B, Mason JC, Perretti M.

Clin Sci (Lond). 2019 Apr 4;133(7):839-851. doi: 10.1042/CS20180415. Print 2019 Apr 15.

13.

2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis.

Ehlers L, Askling J, Bijlsma HW, Cid MC, Cutolo M, Dasgupta B, Dejaco C, Dixon WG, Feltelius N, Finckh A, Gilbert K, Mackie SL, Mahr A, Matteson EL, Neill L, Salvarani C, Schmidt WA, Strangfeld A, van Vollenhoven RF, Buttgereit F.

Ann Rheum Dis. 2019 Sep;78(9):1160-1166. doi: 10.1136/annrheumdis-2018-214755. Epub 2019 Mar 21.

PMID:
30898837
14.

Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.

Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schulze-Koops H, Schett G, Spiera R, Unizony SH, Collinson N.

Arthritis Rheumatol. 2019 Aug;71(8):1329-1338. doi: 10.1002/art.40876. Epub 2019 Jul 3.

15.

Pretreatment optimisation and kinetics of batch anaerobic digestion of liquidised OFMSW treated with NaOH: Models verification with experimental data.

Bala R, Gupta GK, Dasgupta BV, Mondal MK.

J Environ Manage. 2019 May 1;237:313-321. doi: 10.1016/j.jenvman.2019.02.083. Epub 2019 Feb 25.

PMID:
30807977
16.

A probability score to aid the diagnosis of suspected giant cell arteritis.

Laskou F, Coath F, Mackie SL, Banerjee S, Aung T, Dasgupta B.

Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):104-108. Epub 2019 Feb 15.

17.

A serological marker of the N-terminal neoepitope generated during LOXL2 maturation is elevated in patients with cancer or idiopathic pulmonary fibrosis.

Leeming DJ, Willumsen N, Sand JMB, Holm Nielsen S, Dasgupta B, Brodmerkel C, Curran M, Bager CL, Karsdal MA.

Biochem Biophys Rep. 2018 Nov 30;17:38-43. doi: 10.1016/j.bbrep.2018.11.002. eCollection 2019 Mar.

18.

Giant cell arteritis: new concepts, treatments and the unmet need that remains.

Coath F, Gillbert K, Griffiths B, Hall F, Kay L, Lanyon P, Luqmani R, Mackie SL, Mason JC, Mills J, Mollan S, Morgan AW, Mukhtyar C, Quick V, Watts R, Dasgupta B.

Rheumatology (Oxford). 2019 Jul 1;58(7):1316. doi: 10.1093/rheumatology/key411. No abstract available.

PMID:
30544209
19.

Giant cell arteritis: new concepts, treatments and the unmet need that remains.

Coath F, Gillbert K, Griffiths B, Hall F, Kay L, Lanyon P, Luqmani R, Mackie SL, Mason JC, Mills J, Mollan S, Morgan AW, Mukhtyar C, Quick V, Watts R, Dasgupta B.

Rheumatology (Oxford). 2019 Jul 1;58(7):1123-1125. doi: 10.1093/rheumatology/key326. No abstract available.

20.

Plasma and brain pharmacokinetics of letrozole and drug interaction studies with temozolomide in NOD-scid gamma mice and sprague dawley rats.

Arora P, Adams CH, Gudelsky G, DasGupta B, Desai PB.

Cancer Chemother Pharmacol. 2019 Jan;83(1):81-89. doi: 10.1007/s00280-018-3705-6. Epub 2018 Oct 24.

PMID:
30357450
21.

Author Correction: AMP kinase promotes glioblastoma bioenergetics and tumour growth.

Chhipa RR, Fan Q, Anderson J, Muraleedharan R, Huang Y, Ciraolo G, Chen X, Waclaw R, Chow LM, Khuchua Z, Kofron M, Weirauch MT, Kendler A, McPherson C, Ratner N, Nakano I, Dasgupta N, Komurov K, Dasgupta B.

Nat Cell Biol. 2018 Nov;20(11):1328. doi: 10.1038/s41556-018-0203-3.

PMID:
30190576
22.

Publisher Correction: AMP kinase promotes glioblastoma bioenergetics and tumour growth.

Chhipa RR, Fan Q, Anderson J, Muraleedharan R, Huang Y, Ciraolo G, Chen X, Waclaw R, Chow LM, Khuchua Z, Kofron M, Weirauch MT, Kendler A, McPherson C, Ratner N, Nakano I, Dasgupta N, Komurov K, Dasgupta B.

Nat Cell Biol. 2018 Oct;20(10):1228. doi: 10.1038/s41556-018-0185-1.

PMID:
30089841
23.

Prevention of glucocorticoid morbidity in giant cell arteritis.

Buttgereit F, Matteson EL, Dejaco C, Dasgupta B.

Rheumatology (Oxford). 2018 Feb 1;57(suppl_2):ii11-ii21. doi: 10.1093/rheumatology/kex459. Review.

PMID:
29982779
24.

Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises.

Schäfer VS, Chrysidis S, Dejaco C, Duftner C, Iagnocco A, Bruyn GA, Carrara G, D'Agostino MA, De Miguel E, Diamantopoulos AP, Fredberg U, Hartung W, Hocevar A, Juche A, Kermani TA, Koster MJ, Lorenzen T, Macchioni P, Milchert M, Døhn UM, Mukhtyar C, Ponte C, Ramiro S, Scirè CA, Terslev L, Warrington KJ, Dasgupta B, Schmidt WA.

J Rheumatol. 2018 Aug;45(9):1289-1295. doi: 10.3899/jrheum.171428. Epub 2018 Jul 1.

PMID:
29961687
25.

AMP kinase promotes glioblastoma bioenergetics and tumour growth.

Chhipa RR, Fan Q, Anderson J, Muraleedharan R, Huang Y, Ciraolo G, Chen X, Waclaw R, Chow LM, Khuchua Z, Kofron M, Weirauch MT, Kendler A, McPherson C, Ratner N, Nakano I, Dasgupta N, Komurov K, Dasgupta B.

Nat Cell Biol. 2018 Jul;20(7):823-835. doi: 10.1038/s41556-018-0126-z. Epub 2018 Jun 18. Erratum in: Nat Cell Biol. 2018 Aug 8;:. Nat Cell Biol. 2018 Nov;20(11):1328.

26.

Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group.

Chrysidis S, Duftner C, Dejaco C, Schäfer VS, Ramiro S, Carrara G, Scirè CA, Hocevar A, Diamantopoulos AP, Iagnocco A, Mukhtyar C, Ponte C, Naredo E, De Miguel E, Bruyn GA, Warrington KJ, Terslev L, Milchert M, D'Agostino MA, Koster MJ, Rastalsky N, Hanova P, Macchioni P, Kermani TA, Lorenzen T, Døhn UM, Fredberg U, Hartung W, Dasgupta B, Schmidt WA.

RMD Open. 2018 May 17;4(1):e000598. doi: 10.1136/rmdopen-2017-000598. eCollection 2018.

27.
28.

Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial.

Loesche MA, Farahi K, Capone K, Fakharzadeh S, Blauvelt A, Duffin KC, DePrimo SE, Muñoz-Elías EJ, Brodmerkel C, Dasgupta B, Chevrier M, Smith K, Horwinski J, Tyldsley A, Grice EA.

J Invest Dermatol. 2018 Sep;138(9):1973-1981. doi: 10.1016/j.jid.2018.03.1501. Epub 2018 Mar 17.

29.

Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma.

Sadahiro H, Kang KD, Gibson JT, Minata M, Yu H, Shi J, Chhipa R, Chen Z, Lu S, Simoni Y, Furuta T, Sabit H, Zhang S, Bastola S, Yamaguchi S, Alsheikh H, Komarova S, Wang J, Kim SH, Hambardzumyan D, Lu X, Newell EW, DasGupta B, Nakada M, Lee LJ, Nabors B, Norian LA, Nakano I.

Cancer Res. 2018 Jun 1;78(11):3002-3013. doi: 10.1158/0008-5472.CAN-17-2433. Epub 2018 Mar 12.

30.

Compound C/Dorsomorphin: Its Use and Misuse as an AMPK Inhibitor.

Dasgupta B, Seibel W.

Methods Mol Biol. 2018;1732:195-202. doi: 10.1007/978-1-4939-7598-3_12.

PMID:
29480476
31.

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.

Dumusc A, Ng WF, James K, Griffiths B, Price E, Pease C, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Gupta M, McLaren J, Cooper A, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman S.

Swiss Med Wkly. 2018 Feb 7;148:w14588. doi: 10.4414/smw.2018.14588. eCollection 2018.

32.

Profile of tocilizumab and its potential in the treatment of giant cell arteritis.

Mollan SP, Horsburgh J, Dasgupta B.

Eye Brain. 2018 Jan 23;10:1-11. doi: 10.2147/EB.S127812. eCollection 2018. Review.

33.

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.

Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, Brouwer E, Cimmino MA, Clark E, Dasgupta B, Diamantopoulos AP, Direskeneli H, Iagnocco A, Klink T, Neill L, Ponte C, Salvarani C, Slart RHJA, Whitlock M, Schmidt WA.

Ann Rheum Dis. 2018 May;77(5):636-643. doi: 10.1136/annrheumdis-2017-212649. Epub 2018 Jan 22.

34.

Current and emerging therapies in large-vessel vasculitis.

Kermani TA, Dasgupta B.

Rheumatology (Oxford). 2018 Sep 1;57(9):1513-1524. doi: 10.1093/rheumatology/kex385. Review.

PMID:
29069518
35.

Copb2 is essential for embryogenesis and hypomorphic mutations cause human microcephaly.

DiStasio A, Driver A, Sund K, Donlin M, Muraleedharan RM, Pooya S, Kline-Fath B, Kaufman KM, Prows CA, Schorry E, Dasgupta B, Stottmann RW.

Hum Mol Genet. 2017 Dec 15;26(24):4836-4848. doi: 10.1093/hmg/ddx362.

36.

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

Oni C, Mitchell S, James K, Ng WF, Griffiths B, Hindmarsh V, Price E, Pease CT, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Hunter J, Gupta M, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman SJ.

Rheumatology (Oxford). 2017 Dec 1;56(12):2255. doi: 10.1093/rheumatology/kex331. No abstract available.

37.

Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B.

Nat Rev Rheumatol. 2017 Oct;13(10):578-592. doi: 10.1038/nrrheum.2017.142. Epub 2017 Sep 14. Review.

38.

Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study.

Balasubramaniam G, Parker T, Turner D, Parker M, Scales J, Harnett P, Harrison M, Ahmed K, Bhagat S, Marianayagam T, Pitzalis C, Mallen C, Roddy E, Almond M, Dasgupta B.

BMJ Open. 2017 Sep 5;7(9):e017121. doi: 10.1136/bmjopen-2017-017121.

39.

Tocilizumab (Actemra).

Sheppard M, Laskou F, Stapleton PP, Hadavi S, Dasgupta B.

Hum Vaccin Immunother. 2017 Sep 2;13(9):1972-1988. doi: 10.1080/21645515.2017.1316909. Review.

40.

Cathepsin-S degraded decorin are elevated in fibrotic lung disorders - development and biological validation of a new serum biomarker.

Kehlet SN, Bager CL, Willumsen N, Dasgupta B, Brodmerkel C, Curran M, Brix S, Leeming DJ, Karsdal MA.

BMC Pulm Med. 2017 Aug 9;17(1):110. doi: 10.1186/s12890-017-0455-x.

41.

A 26-week feasibility study comparing the efficacy and safety of modified-release prednisone with immediate-release prednisolone in newly diagnosed cases of giant cell arteritis.

Raine C, Stapleton PP, Merinopoulos D, Maw WW, Achilleos K, Gayford D, Mapplebeck S, Mackerness C, Schofield P, Dasgupta B.

Int J Rheum Dis. 2018 Jan;21(1):285-291. doi: 10.1111/1756-185X.13149. Epub 2017 Aug 9.

PMID:
28791802
42.

Trial of Tocilizumab in Giant-Cell Arteritis.

Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, Brouwer E, Cid MC, Dasgupta B, Rech J, Salvarani C, Schett G, Schulze-Koops H, Spiera R, Unizony SH, Collinson N.

N Engl J Med. 2017 Jul 27;377(4):317-328. doi: 10.1056/NEJMoa1613849.

43.

Selection Rule for Enhanced Dark Matter Annihilation.

Das A, Dasgupta B.

Phys Rev Lett. 2017 Jun 23;118(25):251101. doi: 10.1103/PhysRevLett.118.251101. Epub 2017 Jun 23.

PMID:
28696757
44.

Association between characteristics of pain and stiffness and the functional status of patients with incident polymyalgia rheumatica from primary care.

Cawley A, Prior JA, Muller S, Helliwell T, Hider SL, Dasgupta B, Barraclough K, Mallen CD.

Clin Rheumatol. 2018 Jun;37(6):1639-1644. doi: 10.1007/s10067-017-3730-6. Epub 2017 Jun 20.

45.

Minimizing Isolate Catalyst Motion in Metal-Assisted Chemical Etching for Deep Trenching of Silicon Nanohole Array.

Kong L, Zhao Y, Dasgupta B, Ren Y, Hippalgaonkar K, Li X, Chim WK, Chiam SY.

ACS Appl Mater Interfaces. 2017 Jun 21;9(24):20981-20990. doi: 10.1021/acsami.7b04565. Epub 2017 Jun 8.

PMID:
28534611
46.

Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study.

Cutolo M, Hopp M, Liebscher S, Dasgupta B, Buttgereit F.

RMD Open. 2017 Mar 17;3(1):e000426. doi: 10.1136/rmdopen-2016-000426. eCollection 2017.

47.

The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas.

Anderson JL, Muraleedharan R, Oatman N, Klotter A, Sengupta S, Waclaw RR, Wu J, Drissi R, Miles L, Raabe EH, Weirauch ML, Fouladi M, Chow LM, Hoffman L, DeWire M, Dasgupta B.

Neuro Oncol. 2017 Aug 1;19(8):1068-1078. doi: 10.1093/neuonc/now299.

48.

Enhancement of canonical sampling by virtual-state transitions.

Higo J, Kasahara K, Dasgupta B, Nakamura H.

J Chem Phys. 2017 Jan 28;146(4):044104. doi: 10.1063/1.4974087.

PMID:
28147529
49.

Cadaveric Study of Insertional Anatomy of Distal Biceps Tendon and its Relationship to the Dynamic Proximal Radioulnar Space.

Bhatia DN, Kandhari V, DasGupta B.

J Hand Surg Am. 2017 Jan;42(1):e15-e23. doi: 10.1016/j.jhsa.2016.11.004.

PMID:
28052833
50.

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Carmona FD, Vaglio A, Mackie SL, Hernández-Rodríguez J, Monach PA, Castañeda S, Solans R, Morado IC, Narváez J, Ramentol-Sintas M, Pease CT, Dasgupta B, Watts R, Khalidi N, Langford CA, Ytterberg S, Boiardi L, Beretta L, Govoni M, Emmi G, Bonatti F, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Sailler L, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Brouwer E, Daikeler T, Berger CT, Molloy ES, O'Neill L, Blockmans D, Lie BA, Mclaren P, Vyse TJ, Wijmenga C, Allanore Y, Koeleman BPC; Spanish CGA Group; UKGCA Consortium; Vasculitis Clinical Research Consortium, Barrett JH, Cid MC, Salvarani C, Merkel PA, Morgan AW, González-Gay MA, Martín J.

Am J Hum Genet. 2017 Jan 5;100(1):64-74. doi: 10.1016/j.ajhg.2016.11.013. Epub 2016 Dec 29.

Supplemental Content

Loading ...
Support Center